We check all companies for important risks. See what we found for Aroa Biosurgery in our free report. If you want to know who really controls Aroa Biosurgery Limited (ASX:ARX), then you'll have to ...

Aroa surges to profitability in FY25 with a NZ$4.2 million normalised EBITDA profit Reports total revenue for full year of NZ$84.7 million, up 23% and exceeding guidance Provides total revenue ...

Revenue: NZ$84.7m (up 23% from FY 2024). Net loss: NZ$3.81m (loss narrowed by 64% from FY 2024). NZ$0.011 loss per share (improved from NZ$0.031 loss in FY 2024). Revenue exceeded analyst ...

In this episode, Tim chats with Aroa Biosurgery (ASX:ARX) chief financial officer James Agnew about the company's full year financials for FY25. Headquartered in New Zealand, Aroa Biosurgery is ...

New-Zealand-based soft-tissue repair company Aroa Biosurgery is looking in good shape after delivering its first full-year profit since listing on the ASX in 2020. Aroa surges to profitability in ...

We check all companies for important risks. See what we found for Aroa Biosurgery in our free report. If you want to know who really controls Aroa Biosurgery Limited (ASX:ARX), then you'll have to ...

Followed categories will be added to My News. In this episode, Tim chats with Aroa Biosurgery (ASX:ARX) chief financial officer James Agnew about the company's full year financials for FY25.